Blocking somatic repeat expansion and lowering huntingtin by RNAi synergize to attenuate Huntington’s disease pathogenesis in mice | Science Translational Medicine
Combined siRNA-mediated silencing of MSH3 and HTT has synergistic therapeutic effects in a mouse model of Huntington’s disease.